InvestorsHub Logo
Followers 50
Posts 2167
Boards Moderated 0
Alias Born 02/22/2012

Re: None

Thursday, 05/21/2020 6:13:39 PM

Thursday, May 21, 2020 6:13:39 PM

Post# of 27563
iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™
iBio, Inc. ( IBIO ) (“iBio” or the “Company”), a biologics contract manufacturing organization and biotechnology company, today provided an update on its COVID-19 vaccine manufacturing capacity and announced that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (“NIIMBL”), one of 14 institutes in the Manufacturing USA Network.

https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=IBIO&storyid=202004271615PRIMZONEFULLFEED7910259&provider=PRIMZONE&product=FULLFEED&sb=1



[img]
[/img]

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBIO News